UPC Analytics
ENDE
Overview · Filed: Dec 13, 2024

UPC_CoA_810/2024

METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE

AppealsMain AppealCourt of AppealGenericCase Closed
OverviewDecisionsCitationsDocumentsTimeline
Parties

Claimants

  • Curio Bioscience Inc.
Reps: Tilman Mueller-Stoy (Bardehle Pagenberg); Axel Berger (Bardehle Pagenberg)

Respondents

  • 10x Genomics, Inc.
Reps: Cameron Marshall (Carpmaels & Ransford LLP); Agathe Michel-De Cazotte (Carpmaels & Ransford LLP)
Judges
  • Emmanuel Gougé
Patents
  • EP2697391
  • EP 2 697 391 B1
CPC codes: C12Q1/6827, C12Q1/6841, C12Q1/6837, C12Q1/6853, G01N1/30, G16B30/00, C12Q1/6816, C12N15/11, G16B50/20, C12Q1/6844, C12Q1/6876, G16B50/30…

Sector: Biotechnology

Outcome
Dismissed
Filed: Dec 13, 2024
First decided: —
Language: English

The Court of Appeal (standing judge) dismissed Curio Bioscience Inc.'s application for suspensive effect (R. 223.4 RoP) of a Düsseldorf Local Division order requiring Curio to provide security for costs of EUR 200,000 in favour of claimant 10x Genomics Inc. The standing judge held that Curio had not established 'extreme urgency' as required under R. 223 RoP, which is a condition for a standing-judge decision without hearing the respondent.

Open on UPC Registry